F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to provide pharmaceutical services (including procedures that
assure the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals) to
meet the needs of each resident for 1 of 3 residents (Resident #1) reviewed for medication errors.The
facility failed to administer Resident #1's glimepiride (an oral medication used to manage blood sugar levels
in adults with type 2 diabetes). The medication was not available according to the signed MARThis deficient
practice could place residents at risk of inadequate therapeutic outcomes, increased adverse side effects,
and a decline in health.Findings include:Record review of Resident #1's face sheet dated 09/30/25 revealed
an [AGE] year-old male admitted to the facility on [DATE] and re-admitted on [DATE] with diagnoses of type
2 diabetes (chronic medical condition in which the body does not produce enough insulin or does not use
insulin effectively), morbid obesity, and Alzheimer's disease (a progressive disease that destroys memory
and other important mental functions). Record review of Resident #1's most recent quarterly MDS
assessment, dated 6/11/25 revealed the resident had a BIMS score of 10 indicating moderate cognitive
impairment for daily decision-making skills.Record review of Resident #1's care plan dated 08/08/25
indicated Resident #1 used diabetic medications. Interventions included to provide and document teaching
to resident/family/caregiver and address identified roadblocks to compliance Record review of Resident
#1's physician orders included the following medications: Glimepiride oral tablet I mg-Give I tablet by mouth
one time a day for diabetes mellitus-ordered 12/11/2024 Basaglar Kwik Pen subcutaneous solution
Pen-injection 100 unit/ml-Inject 20 unit subcutaneously one time a day relate to type 2 diabetes
mellitus-ordered 02/14/25Becton [NAME] duo miscellaneous 30 g X mm. Inject 1 application
subcutaneously before meals and at bedtime for diabetes mellitus-ordered 04/14/25. Record review of
Resident #1's Medication Administration Record for July 2025 revealed the scheduled medication of
glimepiride I mg was not administered on July 27, 28, 29, 30 and 31, 2025. The medication was to be
administered I tablet by mouth one time a day. Further review of the MAR revealed MA A documented an
UN in the section meant for administered medication indicating unavailable medication for July 28 and 29,
2025. Review also revealed MA C documented UN indicating unavailable for July 27, 30, 31 2025. During
an interview on 09/30/2025 at 9:45a.m, RP P stated she was the responsible party for Resident #1. RP P
stated on 07/26/25, she had a 90-day supply of glimepiride for diabetes delivered to the facility. The staff
lost the medication. The facility informed her that they would have the doctor renew the medication which
they did not do as promised. On 07/31/25, the facility still had no medication for the resident. The RP
explained she complained to the facility corporate office, and DON assured her the facility will provide the
medication and pay for it. She was assured by DON and staff that they had the medication in stock and had
been administering the medication to Resident #1. The RP P stated, the resident may have missed his
medication for more than four days. The RP P explained the glimepiride was a
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
675145
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675145
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Buena Vida Nursing and Rehab Odessa
3800 Englewood LN
Odessa, TX 79762
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
significant medication used for control of his diabetes mellitus. She stated not taking this medicine will
complicate [KS5] the control of his blood sugar resulting in serious harm to his health. In an interview with
MA B on 09/30/25 at 1:30p.m, she stated she was the medication aide working on hall 200 where Resident
#1 was residing. She said she did not give Resident #1 his glimepiride medication on July 28 and 29, 2025
as ordered. This was because the medication was not available. MA A explained that the family supplies the
medication for the resident. She notified the charge nurse that the medication was not available to let the
family know. MA A said she could not remember the charge nurse she informed. MA A added that it was a
common practice to retrieve the medication from the E-kit (emergency kit) but did not remember if the
charge nurse attempted to check the E-kit. She stated the medication was used to treat high blood sugar for
diabetic residents. She noted Resident #1 could get diabetic complications [KS7] for not receiving the
medication as ordered. During interview with MA C on 09/30/25 at 10:11a.m, she stated she has been
working for the facility for 5 years and was responsible for giving medication to Resident #1. MA C
confirmed she signed on Resident #1's MAR on July 27, 30 and 31, 2025 that the diabetic medication of
glimepiride was not available. She stated one of days the medication was not available the resident's was in
the room. The MA C informed wife the resident was out of the medication. MA C said the wife told her she
had already filled the medication. MA C stated Resident #1's wife came back the next day and informed her
the medication was already delivered and somebody from the facility signed for it. The continued and stated
there was no longer a refill left because the order was already filled. MA C said she informed the nurse on
duty of resident's information regarding the delivered medication. The medication aide stated she could not
remember the charge nurse she informed since it has been more than a month. MA C stated she did not
know why it took days before Resident #1 started receiving his medication. She explained, it was normal
protocol to retrieve the medication from the E-kit. She did not know if the charge nurse [KS10] ied to get the
medication from the E-kit. During an interview with DON on 09/30/25 at 10:43a.m, she stated she was not
aware Resident #1 missed his medication of glimepiride for 5 days until the surveyor brought it to her
attention. The DON said she communicated with the corporate office about the medication issue. She
stated a staff member signed for the medication, but they could not locate the medication. She notified the
physician and got the medication refilled. Meanwhile, she was not aware Resident #1 missed so many
days. The DON stated it was lack of communication between the staff and herself. She stated, looking at
the MAR, it appears Resident #1 did not receive medication of glimepiride for 5 days from July 27 through
31, 2025. In an interview with PH D on 10/01/25 at 10:38a.m, he stated he was familiar and responsible for
Resident #1. He said he was made aware that Resident #1 missed some of his medication of glimepiride.
PH D stated he was told to reorder the medication because the facility could not find it after it was
delivered.Record review of the facility document titled Medication Administration and general guidelines
undated reflected the following below. The policy did address the facility E-kit policy.Policy:Medications are
administered as prescribed, in accordance with State Regulations using good nursing principles and
practices and only by persons legally authorized to do so. Personnel authorized to administer medications
do so only after they have familiarized themselves with the medication, monograph of all medications is
available in Link Rx otherwise authorized personnel should refer to Drug Reference material provided by
facility.Procedure:1) Medications are prepared, administered, and recorded only by licensed nursing,
medical, pharmacy, or other personnel authorized by state laws and regulations to administer
medications.2) Medications are administered in accordance with written orders of the attending physician. If
a dose seems excessive considering the resident's age and condition, or a medication order seems to be
unrelated
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675145
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675145
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/20/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Buena Vida Nursing and Rehab Odessa
3800 Englewood LN
Odessa, TX 79762
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
to the resident's current diagnosis or condition, the physician is contacted for clarification prior to the
administration of the medication. The interaction with the physician is documented in the nursing notes and
elsewhere in the medical record as appropriate.3) The person administering medications adheres to
Universal Precautions, using proper hand hygiene, gloves when appropriate, before beginning a medication
pass, prior to handling any medication, and after coming into direct contact with a resident. Gloves will be
worn before administration of any ophthalmic, optic, intranasal, inhaled, topical, vaginal, or rectal
medication.4) Residents are allowed to self-administer medications when specifically authorized by the
attending physician and in accordance with policy and procedure for self-administration of medications.5)
Medications are administered at the time they are prepared. Medications are not pre-poured. 6) All current
medications and dosage schedules, except topicals used for treatments, are listed on the resident's
medication administration record (MAR).
Event ID:
Facility ID:
675145
If continuation sheet
Page 3 of 3